Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A study of computed tomography (CT) scan frequency in patients with stage I testicular teratoma
Source of recordUK Trials
ISRCTNISRCTN56475197
Date ISRCTN assigned06/04/2000
Local reference number(s)TE08
Public titleA study of computed tomography (CT) scan frequency in patients with stage I testicular teratoma
Scientific title
AcronymN/A
Disease/condition/study domainCancer
Study hypothesisTo assess the value of frequent abdominal and chest CT scans in the follow-up of patients with stage I non-seminomatous germ cell tumours (NSGCT) who are on a surveillance programme. After baseline scans confirming stage I disease, patients will be randomised between two and five further CT scans during their follow up, with the nature and frequency of all other investigations remaining constant.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration.
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Histologically confirmed stage I non-seminomatous germ cell tumour of the testis
2. Patients must be able to attend for regular surveillance
3. The interval between orchidectomy and randomisation should not exceed 8 weeks
4. No co-existent or previously treated malignant disease, except successfully treated non-melanotic skin cancer
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/12/1997
Anticipated end date30/04/2003
Status of trialCompleted
Target number of participants900
Interventions1. One group receives two CT scans
2. The other group receives five CT scans
Primary outcome measure(s)Stage of the disease at relapse (IGCC Classification), time from entry to detection of relapse.
Secondary outcome measure(s)Overall survival, identification of the first investigation or sign prompting diagnosis of relapse, incidence of second malignancies and balance of costs of treatment determined through health economics study
Trial websitehttp://www.ctu.mrc.ac.uk/studies/TE08.asp
PublicationsResults on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17416851
Sources of fundingMedical Research Council (UK)
Sponsor nameMedical Research Council (UK)
Sponsor details20 Park Crescent
London
United Kingdom
W1B 1AL
Sponsor telephone+44 (0)20 7636 5422
Sponsor fax+44 (0)20 7436 6179
Sponsor emailclinical.trial@headoffice.mrc.ac.uk
Sponsor websitehttp://www.mrc.ac.uk
Contact nameMiss Sharon Naylor
Contact detailsMRC Clinical Trials Unit
222 Euston Road
London
United Kingdom
NW1 2DA
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN56475197
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central